Share Price and Basic Stock Data
Last Updated: February 7, 2026, 7:32 pm
| PEG Ratio | 1.19 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kokuyo Camlin Ltd operates in the printing, publishing, and stationery sector, with a current market capitalization of ₹825 Cr and a share price of ₹82.2. The company reported sales of ₹775 Cr for FY 2023, an increase from ₹508 Cr in FY 2022, reflecting a strong recovery post-pandemic. The revenue trajectory from the quarterly data shows a notable peak in June 2023, with sales reaching ₹235.79 Cr, followed by a dip to ₹194.84 Cr in September 2023. However, the sales trend appears to be stabilizing, with ₹217.23 Cr and ₹229.42 Cr projected for March and June 2024, respectively. This robust performance indicates effective demand management and operational recovery, especially given the challenging market conditions faced by the stationery industry. The company’s continuous efforts in product innovation and market expansion have likely contributed to this upward trend, positioning it favorably against competitors in the sector.
Profitability and Efficiency Metrics
The profitability of Kokuyo Camlin Ltd has demonstrated fluctuations, with a reported operating profit margin (OPM) of 9.25% as of September 2025, which is relatively low compared to industry standards. The company recorded an operating profit of ₹54 Cr in FY 2023, increasing to ₹77 Cr in FY 2024, showcasing improved operational efficiency. However, the net profit stood at ₹18 Cr for FY 2023, which is modest given the overall revenue growth. The interest coverage ratio (ICR) is a solid 4.53x, indicating that the company can comfortably meet its interest obligations. Nevertheless, the return on equity (ROE) at 1.95% and return on capital employed (ROCE) at 3.65% are below optimal levels, suggesting room for improvement in capital efficiency. The company’s ability to manage expenses effectively will be crucial in enhancing profitability, as indicated by the operating profit trends in quarterly reports.
Balance Sheet Strength and Financial Ratios
Kokuyo Camlin Ltd’s balance sheet reflects a conservative financial stance, with total borrowings reported at ₹12 Cr, significantly lower than the reserves of ₹312 Cr, indicating a strong net asset position. The company’s current ratio stands at 1.32, suggesting adequate liquidity to meet short-term obligations. The debt-to-equity ratio of 0.02 signifies minimal leverage, which may appeal to risk-averse investors. However, the price-to-book value ratio of 3.89x indicates that the stock may be trading at a premium relative to its book value, potentially limiting upside for new investors. The cash conversion cycle (CCC) is reported at 109 days, which aligns with industry norms but indicates room for improvement in operational efficiency. A focus on reducing the CCC could enhance cash flow and profitability further, allowing the company to reinvest in growth opportunities.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Kokuyo Camlin Ltd reveals a strong promoter backing at 74.99%, which provides stability and confidence to other investors. The public shareholding stands at 24.92%, with a total of 32,955 shareholders, reflecting a broad base of retail investor participation. However, foreign institutional investors (FIIs) hold a mere 0.09%, indicating limited interest from international investors. This low FII participation could hinder the stock’s liquidity and market perception. The lack of domestic institutional investment (DIIs) further emphasizes a potential area for growth in attracting institutional capital. The stability provided by promoters, coupled with the need for broader institutional support, will be essential in fostering investor confidence and enhancing the stock’s market performance in the long term.
Outlook, Risks, and Final Insight
Kokuyo Camlin Ltd’s outlook hinges on its ability to sustain revenue growth and improve profitability metrics in a competitive market. The risks include potential fluctuations in raw material costs, which could impact profit margins, and the reliance on a limited product range that may expose the company to market volatility. Additionally, with a low ROE and ROCE, the company must focus on enhancing operational efficiencies to attract more institutional investors and improve shareholder returns. Conversely, strengths such as a solid balance sheet, low debt levels, and a strong promoter backing provide a foundation for future growth. If Kokuyo Camlin can successfully innovate and expand its product offerings while managing costs, it may enhance its market position and profitability. The company’s ability to navigate these challenges will determine its long-term success in the stationery industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| H T Media Ltd | 522 Cr. | 22.4 | 28.6/14.5 | 11.9 | 71.0 | 0.00 % | 2.51 % | 0.03 % | 2.00 |
| Gala Global Products Ltd | 8.68 Cr. | 1.59 | 3.96/1.54 | 6.54 | 0.00 % | 1.82 % | 12.3 % | 5.00 | |
| Flair Writing Industries Ltd | 3,203 Cr. | 304 | 357/194 | 27.5 | 100.0 | 0.33 % | 15.6 % | 11.9 % | 5.00 |
| Doms Industries Ltd | 14,681 Cr. | 2,419 | 3,065/2,250 | 66.2 | 181 | 0.13 % | 26.2 % | 22.3 % | 10.0 |
| DB Corp Ltd | 4,232 Cr. | 237 | 292/189 | 13.1 | 129 | 5.05 % | 21.1 % | 16.7 % | 10.0 |
| Industry Average | 2,433.94 Cr | 388.47 | 20.11 | 207.90 | 1.13% | 9.39% | 9.69% | 6.27 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 172.69 | 216.25 | 235.79 | 194.84 | 168.03 | 217.23 | 229.42 | 172.51 | 160.56 | 200.03 | 227.39 | 174.38 | 177.97 |
| Expenses | 163.75 | 199.09 | 211.57 | 177.54 | 155.52 | 194.68 | 201.64 | 180.11 | 160.12 | 186.83 | 207.76 | 158.25 | 166.49 |
| Operating Profit | 8.94 | 17.16 | 24.22 | 17.30 | 12.51 | 22.55 | 27.78 | -7.60 | 0.44 | 13.20 | 19.63 | 16.13 | 11.48 |
| OPM % | 5.18% | 7.94% | 10.27% | 8.88% | 7.45% | 10.38% | 12.11% | -4.41% | 0.27% | 6.60% | 8.63% | 9.25% | 6.45% |
| Other Income | 1.71 | 0.25 | 4.96 | 0.20 | 0.13 | 0.39 | 0.86 | -0.20 | 0.14 | -0.05 | 0.11 | 0.19 | 0.16 |
| Interest | 1.00 | 1.52 | 1.15 | 0.48 | 0.81 | 1.78 | 1.60 | 1.00 | 1.00 | 1.01 | 0.92 | 0.42 | 0.41 |
| Depreciation | 4.14 | 4.24 | 4.24 | 4.44 | 4.56 | 5.42 | 5.35 | 5.28 | 5.23 | 5.34 | 5.29 | 5.32 | 5.31 |
| Profit before tax | 5.51 | 11.65 | 23.79 | 12.58 | 7.27 | 15.74 | 21.69 | -14.08 | -5.65 | 6.80 | 13.53 | 10.58 | 5.92 |
| Tax % | 36.48% | 24.81% | 22.78% | 24.64% | 23.52% | 33.80% | 25.08% | -24.50% | -26.19% | 35.44% | 25.65% | 25.61% | 32.77% |
| Net Profit | 3.50 | 8.76 | 18.37 | 9.48 | 5.57 | 10.42 | 16.24 | -10.63 | -4.16 | 4.39 | 10.06 | 7.86 | 3.98 |
| EPS in Rs | 0.35 | 0.87 | 1.83 | 0.95 | 0.56 | 1.04 | 1.62 | -1.06 | -0.41 | 0.44 | 1.00 | 0.78 | 0.40 |
Last Updated: February 5, 2026, 6:16 am
Below is a detailed analysis of the quarterly data for Kokuyo Camlin Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 177.97 Cr.. The value appears strong and on an upward trend. It has increased from 174.38 Cr. (Sep 2025) to 177.97 Cr., marking an increase of 3.59 Cr..
- For Expenses, as of Dec 2025, the value is 166.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 158.25 Cr. (Sep 2025) to 166.49 Cr., marking an increase of 8.24 Cr..
- For Operating Profit, as of Dec 2025, the value is 11.48 Cr.. The value appears to be declining and may need further review. It has decreased from 16.13 Cr. (Sep 2025) to 11.48 Cr., marking a decrease of 4.65 Cr..
- For OPM %, as of Dec 2025, the value is 6.45%. The value appears to be declining and may need further review. It has decreased from 9.25% (Sep 2025) to 6.45%, marking a decrease of 2.80%.
- For Other Income, as of Dec 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 0.19 Cr. (Sep 2025) to 0.16 Cr., marking a decrease of 0.03 Cr..
- For Interest, as of Dec 2025, the value is 0.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.42 Cr. (Sep 2025) to 0.41 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Dec 2025, the value is 5.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.32 Cr. (Sep 2025) to 5.31 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Dec 2025, the value is 5.92 Cr.. The value appears to be declining and may need further review. It has decreased from 10.58 Cr. (Sep 2025) to 5.92 Cr., marking a decrease of 4.66 Cr..
- For Tax %, as of Dec 2025, the value is 32.77%. The value appears to be increasing, which may not be favorable. It has increased from 25.61% (Sep 2025) to 32.77%, marking an increase of 7.16%.
- For Net Profit, as of Dec 2025, the value is 3.98 Cr.. The value appears to be declining and may need further review. It has decreased from 7.86 Cr. (Sep 2025) to 3.98 Cr., marking a decrease of 3.88 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.40. The value appears to be declining and may need further review. It has decreased from 0.78 (Sep 2025) to 0.40, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:05 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 468 | 544 | 614 | 630 | 630 | 689 | 634 | 403 | 508 | 775 | 816 | 763 | 762 |
| Expenses | 465 | 527 | 590 | 606 | 591 | 637 | 597 | 394 | 492 | 721 | 739 | 729 | 713 |
| Operating Profit | 3 | 17 | 25 | 24 | 39 | 51 | 37 | 9 | 17 | 54 | 77 | 34 | 49 |
| OPM % | 1% | 3% | 4% | 4% | 6% | 7% | 6% | 2% | 3% | 7% | 9% | 4% | 6% |
| Other Income | 1 | 8 | 5 | 3 | 2 | 1 | 1 | 0 | 0 | 2 | 6 | 1 | 0 |
| Interest | 9 | 10 | 11 | 12 | 10 | 12 | 10 | 9 | 4 | 4 | 4 | 5 | 3 |
| Depreciation | 9 | 11 | 12 | 12 | 17 | 18 | 19 | 18 | 18 | 17 | 19 | 21 | 21 |
| Profit before tax | -13 | 4 | 7 | 2 | 15 | 23 | 9 | -18 | -5 | 35 | 59 | 9 | 25 |
| Tax % | -12% | -15% | 28% | 33% | 34% | 33% | 50% | -20% | 0% | 30% | 26% | 33% | |
| Net Profit | -12 | 5 | 5 | 2 | 10 | 15 | 4 | -15 | -5 | 24 | 44 | 6 | 18 |
| EPS in Rs | -1.15 | 0.49 | 0.52 | 0.15 | 0.98 | 1.52 | 0.43 | -1.46 | -0.47 | 2.44 | 4.37 | 0.58 | 1.81 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 21% | 11% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 141.67% | 0.00% | -60.00% | 400.00% | 50.00% | -73.33% | -475.00% | 66.67% | 580.00% | 83.33% | -86.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | -141.67% | -60.00% | 460.00% | -350.00% | -123.33% | -401.67% | 541.67% | 513.33% | -496.67% | -169.70% |
Kokuyo Camlin Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 14% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 49% |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 4% |
| 3 Years: | 8% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 9:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 199 | 203 | 208 | 218 | 228 | 239 | 239 | 234 | 229 | 253 | 286 | 292 | 312 |
| Borrowings | 71 | 73 | 99 | 138 | 138 | 173 | 126 | 78 | 70 | 56 | 80 | 54 | 12 |
| Other Liabilities | 113 | 132 | 130 | 114 | 108 | 132 | 106 | 68 | 79 | 124 | 116 | 98 | 113 |
| Total Liabilities | 393 | 418 | 447 | 481 | 485 | 555 | 481 | 390 | 389 | 442 | 493 | 455 | 446 |
| Fixed Assets | 79 | 107 | 105 | 102 | 159 | 165 | 178 | 165 | 149 | 140 | 161 | 159 | 158 |
| CWIP | 6 | 1 | 25 | 50 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 10 | 11 | 6 | 5 | 14 | 14 | 13 | 10 | 16 | 18 |
| Other Assets | 307 | 309 | 317 | 320 | 316 | 383 | 297 | 211 | 225 | 290 | 322 | 280 | 270 |
| Total Assets | 393 | 418 | 447 | 481 | 485 | 555 | 481 | 390 | 389 | 442 | 493 | 455 | 446 |
Below is a detailed analysis of the balance sheet data for Kokuyo Camlin Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 312.00 Cr.. The value appears strong and on an upward trend. It has increased from 292.00 Cr. (Mar 2025) to 312.00 Cr., marking an increase of 20.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 54.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 42.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 113.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 98.00 Cr. (Mar 2025) to 113.00 Cr., marking an increase of 15.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 446.00 Cr.. The value appears to be improving (decreasing). It has decreased from 455.00 Cr. (Mar 2025) to 446.00 Cr., marking a decrease of 9.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 159.00 Cr. (Mar 2025) to 158.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 270.00 Cr.. The value appears to be declining and may need further review. It has decreased from 280.00 Cr. (Mar 2025) to 270.00 Cr., marking a decrease of 10.00 Cr..
- For Total Assets, as of Sep 2025, the value is 446.00 Cr.. The value appears to be declining and may need further review. It has decreased from 455.00 Cr. (Mar 2025) to 446.00 Cr., marking a decrease of 9.00 Cr..
Notably, the Reserves (312.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -68.00 | -56.00 | -74.00 | -114.00 | -99.00 | -122.00 | -89.00 | -69.00 | -53.00 | -2.00 | -3.00 | -20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 52 | 54 | 62 | 63 | 62 | 43 | 46 | 43 | 35 | 37 | 36 |
| Inventory Days | 130 | 131 | 119 | 129 | 152 | 178 | 176 | 196 | 148 | 119 | 141 | 112 |
| Days Payable | 105 | 106 | 95 | 73 | 71 | 80 | 68 | 59 | 56 | 55 | 49 | 39 |
| Cash Conversion Cycle | 80 | 76 | 78 | 118 | 145 | 161 | 152 | 184 | 136 | 99 | 129 | 109 |
| Working Capital Days | 24 | 22 | 24 | 16 | 31 | 40 | 47 | 63 | 52 | 43 | 56 | 58 |
| ROCE % | 0% | 5% | 6% | 4% | 7% | 9% | 5% | -3% | -0% | 12% | 17% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 1.52 | 0.98 | 0.15 | 0.52 | 0.50 |
| Diluted EPS (Rs.) | 1.52 | 0.98 | 0.15 | 0.52 | 0.50 |
| Cash EPS (Rs.) | 3.30 | 2.62 | 1.35 | 1.71 | 1.58 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 24.81 | 23.76 | 22.72 | 21.81 | 21.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 24.81 | 23.76 | 22.72 | 21.81 | 21.29 |
| Revenue From Operations / Share (Rs.) | 68.67 | 62.76 | 62.77 | 61.23 | 54.22 |
| PBDIT / Share (Rs.) | 5.20 | 4.09 | 2.60 | 2.98 | 2.49 |
| PBIT / Share (Rs.) | 3.41 | 2.44 | 1.40 | 1.80 | 1.40 |
| PBT / Share (Rs.) | 2.27 | 1.48 | 0.22 | 0.72 | 0.42 |
| Net Profit / Share (Rs.) | 1.52 | 0.97 | 0.14 | 0.52 | 0.49 |
| NP After MI And SOA / Share (Rs.) | 1.52 | 0.97 | 0.15 | 0.52 | 0.50 |
| PBDIT Margin (%) | 7.56 | 6.51 | 4.14 | 4.86 | 4.60 |
| PBIT Margin (%) | 4.97 | 3.89 | 2.22 | 2.93 | 2.58 |
| PBT Margin (%) | 3.30 | 2.36 | 0.35 | 1.19 | 0.78 |
| Net Profit Margin (%) | 2.20 | 1.55 | 0.23 | 0.85 | 0.90 |
| NP After MI And SOA Margin (%) | 2.20 | 1.55 | 0.24 | 0.85 | 0.92 |
| Return on Networth / Equity (%) | 6.10 | 4.11 | 0.66 | 2.39 | 2.35 |
| Return on Capital Employeed (%) | 12.00 | 9.63 | 5.66 | 6.95 | 5.94 |
| Return On Assets (%) | 2.74 | 2.02 | 0.31 | 1.16 | 1.20 |
| Long Term Debt / Equity (X) | 0.10 | 0.04 | 0.06 | 0.11 | 0.04 |
| Total Debt / Equity (X) | 0.67 | 0.55 | 0.56 | 0.43 | 0.32 |
| Asset Turnover Ratio (%) | 1.32 | 1.30 | 1.36 | 1.42 | 1.34 |
| Current Ratio (X) | 1.32 | 1.25 | 1.18 | 1.57 | 1.59 |
| Quick Ratio (X) | 0.57 | 0.56 | 0.57 | 0.90 | 0.90 |
| Inventory Turnover Ratio (X) | 1.47 | 1.58 | 1.88 | 1.91 | 1.97 |
| Interest Coverage Ratio (X) | 4.53 | 4.27 | 2.22 | 2.79 | 2.56 |
| Interest Coverage Ratio (Post Tax) (X) | 2.32 | 2.02 | 1.13 | 1.49 | 1.50 |
| Enterprise Value (Cr.) | 1125.92 | 1289.55 | 1011.53 | 855.59 | 732.38 |
| EV / Net Operating Revenue (X) | 1.63 | 2.05 | 1.61 | 1.39 | 1.35 |
| EV / EBITDA (X) | 21.61 | 31.45 | 38.79 | 28.61 | 29.27 |
| MarketCap / Net Operating Revenue (X) | 1.41 | 1.84 | 1.43 | 1.35 | 1.36 |
| Price / BV (X) | 3.89 | 4.87 | 3.94 | 3.79 | 3.46 |
| Price / Net Operating Revenue (X) | 1.41 | 1.84 | 1.43 | 1.35 | 1.36 |
| EarningsYield | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
After reviewing the key financial ratios for Kokuyo Camlin Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 19, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 5. It has increased from 0.98 (Mar 18) to 1.52, marking an increase of 0.54.
- For Diluted EPS (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 5. It has increased from 0.98 (Mar 18) to 1.52, marking an increase of 0.54.
- For Cash EPS (Rs.), as of Mar 19, the value is 3.30. This value is within the healthy range. It has increased from 2.62 (Mar 18) to 3.30, marking an increase of 0.68.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 24.81. It has increased from 23.76 (Mar 18) to 24.81, marking an increase of 1.05.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 24.81. It has increased from 23.76 (Mar 18) to 24.81, marking an increase of 1.05.
- For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 68.67. It has increased from 62.76 (Mar 18) to 68.67, marking an increase of 5.91.
- For PBDIT / Share (Rs.), as of Mar 19, the value is 5.20. This value is within the healthy range. It has increased from 4.09 (Mar 18) to 5.20, marking an increase of 1.11.
- For PBIT / Share (Rs.), as of Mar 19, the value is 3.41. This value is within the healthy range. It has increased from 2.44 (Mar 18) to 3.41, marking an increase of 0.97.
- For PBT / Share (Rs.), as of Mar 19, the value is 2.27. This value is within the healthy range. It has increased from 1.48 (Mar 18) to 2.27, marking an increase of 0.79.
- For Net Profit / Share (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 2. It has increased from 0.97 (Mar 18) to 1.52, marking an increase of 0.55.
- For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 2. It has increased from 0.97 (Mar 18) to 1.52, marking an increase of 0.55.
- For PBDIT Margin (%), as of Mar 19, the value is 7.56. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 18) to 7.56, marking an increase of 1.05.
- For PBIT Margin (%), as of Mar 19, the value is 4.97. This value is below the healthy minimum of 10. It has increased from 3.89 (Mar 18) to 4.97, marking an increase of 1.08.
- For PBT Margin (%), as of Mar 19, the value is 3.30. This value is below the healthy minimum of 10. It has increased from 2.36 (Mar 18) to 3.30, marking an increase of 0.94.
- For Net Profit Margin (%), as of Mar 19, the value is 2.20. This value is below the healthy minimum of 5. It has increased from 1.55 (Mar 18) to 2.20, marking an increase of 0.65.
- For NP After MI And SOA Margin (%), as of Mar 19, the value is 2.20. This value is below the healthy minimum of 8. It has increased from 1.55 (Mar 18) to 2.20, marking an increase of 0.65.
- For Return on Networth / Equity (%), as of Mar 19, the value is 6.10. This value is below the healthy minimum of 15. It has increased from 4.11 (Mar 18) to 6.10, marking an increase of 1.99.
- For Return on Capital Employeed (%), as of Mar 19, the value is 12.00. This value is within the healthy range. It has increased from 9.63 (Mar 18) to 12.00, marking an increase of 2.37.
- For Return On Assets (%), as of Mar 19, the value is 2.74. This value is below the healthy minimum of 5. It has increased from 2.02 (Mar 18) to 2.74, marking an increase of 0.72.
- For Long Term Debt / Equity (X), as of Mar 19, the value is 0.10. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 18) to 0.10, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 19, the value is 0.67. This value is within the healthy range. It has increased from 0.55 (Mar 18) to 0.67, marking an increase of 0.12.
- For Asset Turnover Ratio (%), as of Mar 19, the value is 1.32. It has increased from 1.30 (Mar 18) to 1.32, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 19, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.25 (Mar 18) to 1.32, marking an increase of 0.07.
- For Quick Ratio (X), as of Mar 19, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 18) to 0.57, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 19, the value is 1.47. This value is below the healthy minimum of 4. It has decreased from 1.58 (Mar 18) to 1.47, marking a decrease of 0.11.
- For Interest Coverage Ratio (X), as of Mar 19, the value is 4.53. This value is within the healthy range. It has increased from 4.27 (Mar 18) to 4.53, marking an increase of 0.26.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 2.32. This value is below the healthy minimum of 3. It has increased from 2.02 (Mar 18) to 2.32, marking an increase of 0.30.
- For Enterprise Value (Cr.), as of Mar 19, the value is 1,125.92. It has decreased from 1,289.55 (Mar 18) to 1,125.92, marking a decrease of 163.63.
- For EV / Net Operating Revenue (X), as of Mar 19, the value is 1.63. This value is within the healthy range. It has decreased from 2.05 (Mar 18) to 1.63, marking a decrease of 0.42.
- For EV / EBITDA (X), as of Mar 19, the value is 21.61. This value exceeds the healthy maximum of 15. It has decreased from 31.45 (Mar 18) to 21.61, marking a decrease of 9.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 1.41. This value is within the healthy range. It has decreased from 1.84 (Mar 18) to 1.41, marking a decrease of 0.43.
- For Price / BV (X), as of Mar 19, the value is 3.89. This value exceeds the healthy maximum of 3. It has decreased from 4.87 (Mar 18) to 3.89, marking a decrease of 0.98.
- For Price / Net Operating Revenue (X), as of Mar 19, the value is 1.41. This value is within the healthy range. It has decreased from 1.84 (Mar 18) to 1.41, marking a decrease of 0.43.
- For EarningsYield, as of Mar 19, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 18) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kokuyo Camlin Ltd:
- Net Profit Margin: 2.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12% (Industry Average ROCE: 9.39%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.1% (Industry Average ROE: 9.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.32
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32 (Industry average Stock P/E: 20.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.67
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Printing/Publishing/Stationery | Hilton House, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dilip Dandekar | Chairman & Non-Exe.Director |
| Mr. Masaharu Inoue | Senior Vice Chairman |
| Mr. Shriram Dandekar | Vice Chairman & Exe.Director |
| Mr. Satish Veerappa | Managing Director |
| Mr. Takeo lguchi | Executive Director |
| Ms. Nandini Chopra | Independent Director |
| Ms. Naho Shigeta | Independent Director |
| Mr. Nilesh Modi | Independent Director |
| Mr. Naganath Subramanian Iyer | Independent Director |
| Mr. Tomoya Okada | Independent Director |
FAQ
What is the intrinsic value of Kokuyo Camlin Ltd?
Kokuyo Camlin Ltd's intrinsic value (as of 08 February 2026) is ₹20.72 which is 75.27% lower the current market price of ₹83.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹841 Cr. market cap, FY2025-2026 high/low of ₹138/80.0, reserves of ₹312 Cr, and liabilities of ₹446 Cr.
What is the Market Cap of Kokuyo Camlin Ltd?
The Market Cap of Kokuyo Camlin Ltd is 841 Cr..
What is the current Stock Price of Kokuyo Camlin Ltd as on 08 February 2026?
The current stock price of Kokuyo Camlin Ltd as on 08 February 2026 is ₹83.8.
What is the High / Low of Kokuyo Camlin Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kokuyo Camlin Ltd stocks is ₹138/80.0.
What is the Stock P/E of Kokuyo Camlin Ltd?
The Stock P/E of Kokuyo Camlin Ltd is 32.0.
What is the Book Value of Kokuyo Camlin Ltd?
The Book Value of Kokuyo Camlin Ltd is 32.1.
What is the Dividend Yield of Kokuyo Camlin Ltd?
The Dividend Yield of Kokuyo Camlin Ltd is 0.00 %.
What is the ROCE of Kokuyo Camlin Ltd?
The ROCE of Kokuyo Camlin Ltd is 3.65 %.
What is the ROE of Kokuyo Camlin Ltd?
The ROE of Kokuyo Camlin Ltd is 1.95 %.
What is the Face Value of Kokuyo Camlin Ltd?
The Face Value of Kokuyo Camlin Ltd is 1.00.